These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7503966

  • 21. High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy.
    Husson RN, Shirasaka T, Butler KM, Pizzo PA, Mitsuya H.
    J Pediatr; 1993 Jul; 123(1):9-16. PubMed ID: 8391570
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Relevance of AIDS treatment with two nucleoside analogues alone.
    Weidle PJ, Mbidde E, Djomand G, Lackritz EM.
    Lancet; 1999 Jun 12; 353(9169):1989-90. PubMed ID: 10376610
    [No Abstract] [Full Text] [Related]

  • 24. Confirmation for combination AIDS therapy.
    Science; 1995 Oct 06; 270(5233):33. PubMed ID: 7569948
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial).
    Antivir Ther; 2002 Mar 06; 7(1):11-20. PubMed ID: 12008783
    [Abstract] [Full Text] [Related]

  • 27. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG, Moyle GJ.
    Antivir Ther; 1997 Jul 06; 2(3):135-47. PubMed ID: 11322269
    [Abstract] [Full Text] [Related]

  • 28. New trials reach same conclusion: two drugs are better than AZT alone.
    AIDS Alert; 1995 Nov 06; 10(11):133-6. PubMed ID: 11362921
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.
    Kastrissios H, Suárez JR, Katzenstein D, Girard P, Sheiner LB, Blaschke TF.
    AIDS; 1998 Dec 03; 12(17):2295-303. PubMed ID: 9863872
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Zidovudine plus didanosine in primary HIV-1 infection.
    Perrin L, Yerly S, Charvier A, Figueras G, Schockmel GA, Hirschel B.
    Antivir Ther; 1997 Jan 03; 2(1):5-11. PubMed ID: 11322267
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan 03; 92(8):407. PubMed ID: 8582889
    [No Abstract] [Full Text] [Related]

  • 38. Resisting the temptation.
    Lancet; 1993 Aug 21; 342(8869):448. PubMed ID: 7688842
    [No Abstract] [Full Text] [Related]

  • 39. [Anti-retrovirals].
    Roca B, Simón E.
    Med Clin (Barc); 1997 Jun 07; 109(2):62-7. PubMed ID: 9280805
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.